T1	Treatment 39 69	histatin-containing mouthrinse
T2	Treatment 121 166	P-113, a 12 amino acid histatin-based peptide
T3	Treatment 187 209	mouthrinse formulation
T4	Treatment 407 540	self-administered either 0.005%, 0.01%, 0.05% P-113 or placebo mouthrinse formulations twice daily over a four week treatment period.
T5	Treatment 764 781	P-113 mouthrinse.
T6	Treatment 1036 1041	P-113
T7	Treatment 1211 1227	P-113 mouthrinse
